112 related articles for article (PubMed ID: 207051)
1. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
Sonnenschein B
Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
[TBL] [Abstract][Full Text] [Related]
2. The titration of clostridial toxoids and antisera in cell culture.
Knight PA; Burnett C; Whitaker AM; Queminet J
Dev Biol Stand; 1986; 64():129-36. PubMed ID: 2878845
[TBL] [Abstract][Full Text] [Related]
3. [Comparative evaluation of the methods of determining perfringens A antitoxin].
Shemanova GF; Trapezov EV; Musina EE; Vlasova EV; Panteleev EI
Biull Eksp Biol Med; 1983 Nov; 96(11):82-4. PubMed ID: 6315110
[TBL] [Abstract][Full Text] [Related]
4. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
Ligieza J; Reiss J
Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
[TBL] [Abstract][Full Text] [Related]
5. Antigenic hemagglutination inhibition test in examining of the culture supernatants of Clostridium botulinum types A, B, E, and F and some related bacterial species.
Reiss J; Wojtyła B; Lipko A
Arch Immunol Ther Exp (Warsz); 1983; 31(4):531-9. PubMed ID: 6200089
[TBL] [Abstract][Full Text] [Related]
6. An international survey of clostridial sera and vaccines.
Davidson I
Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
[TBL] [Abstract][Full Text] [Related]
7. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
Dezfulian M; Bartlett JG
J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
[TBL] [Abstract][Full Text] [Related]
8. Clostridium botulinum subtype Ba.
Giménez DF
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
[TBL] [Abstract][Full Text] [Related]
9. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
Ligieza J; Reiss J; Michalik M
Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
[TBL] [Abstract][Full Text] [Related]
10. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
Johnson HM; Brenner K; Angelotti R; Hall HE
J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
[TBL] [Abstract][Full Text] [Related]
11. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
Sharma SK; Ferreira JL; Eblen BS; Whiting RC
Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
[TBL] [Abstract][Full Text] [Related]
12. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
Dezfulian M; Bartlett JG
Diagn Microbiol Infect Dis; 1991; 14(1):11-5. PubMed ID: 2013205
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of shared antigens in the genus Clostridium by an enzyme-linked immunosorbent assay.
Poxton IR; Byrne MD
J Med Microbiol; 1984 Apr; 17(2):171-6. PubMed ID: 6323714
[TBL] [Abstract][Full Text] [Related]
14. [Toxoids of botulinum toxin type G].
Puig de Centorbi ON; Ciccarelli AS; Giménez DF
Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
[TBL] [Abstract][Full Text] [Related]
15. The antigenicity of Clostridium botulinum type C toxin administered per os.
Jansen BC; Knoetze PC; Visser F
Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
[No Abstract] [Full Text] [Related]
16. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
[No Abstract] [Full Text] [Related]
17. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
[TBL] [Abstract][Full Text] [Related]
18. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
Rymkiewicz D; Sawicki J; Brühl A
Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
[TBL] [Abstract][Full Text] [Related]
19. [Development of in vitro methods for the potency testing of clostridial vaccines].
Borrmann E; Schulze F; Diller R
ALTEX; 2001; 18(1):34-6. PubMed ID: 11248848
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the serodiagnostic reactions of the bacterium Clostridium butyricum strain CNRZ 528 using passive hemagglutination].
Prösch S; Benedix A
Allerg Immunol (Leipz); 1982; 28(4):260-71. PubMed ID: 6219561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
